148 related articles for article (PubMed ID: 8948355)
21. Relative biological effectiveness enhancement of a 125I brachytherapy seed with characteristic x rays from its constitutive materials.
Taschereau R; Roy R; Pouliot J
Med Phys; 2002 Jul; 29(7):1397-402. PubMed ID: 12148718
[TBL] [Abstract][Full Text] [Related]
22. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
Thomson RM; Rogers DW
Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
[TBL] [Abstract][Full Text] [Related]
23. Dose rate dependence of the relative biological effectiveness of 103Pd for continuous low dose rate irradiation of BA1112 rhabdomyosarcoma cells in vitro relative to acute exposures.
Nath R; Bongiorni P; Chen Z; Gragnano J; Rockwell S
Int J Radiat Biol; 2005 Sep; 81(9):689-99. PubMed ID: 16368647
[TBL] [Abstract][Full Text] [Related]
24. THE DETERMINATION OF NEUTRON FLUENCE TO ABSORBED DOSE CONVERSION COEFFICIENTS AND RELATIVE BIOLOGICAL EFFECT BASED ON MICRODOSIMETRY MEASUREMENTS.
Zhang W; Li C; Zou Y; Liu Y; Luo H
Radiat Prot Dosimetry; 2019 Dec; 187(2):262-267. PubMed ID: 31251366
[TBL] [Abstract][Full Text] [Related]
25. Calculation of relative biological effectiveness of a low-energy electronic brachytherapy source.
Reniers B; Liu D; Rusch T; Verhaegen F
Phys Med Biol; 2008 Dec; 53(24):7125-35. PubMed ID: 19033642
[TBL] [Abstract][Full Text] [Related]
26. Some treatment planning considerations for 103Pd and 125I permanent interstitial implants.
Nath R; Meigooni AS; Melillo A
Int J Radiat Oncol Biol Phys; 1992; 22(5):1131-8. PubMed ID: 1555965
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
[TBL] [Abstract][Full Text] [Related]
28. Tissue inhomogeneity correction for brachytherapy sources in a heterogeneous phantom with cylindrical symmetry.
Meigooni AS; Nath R
Med Phys; 1992; 19(2):401-7. PubMed ID: 1584139
[TBL] [Abstract][Full Text] [Related]
29. Relative biological effectiveness of 103Pd and 125I photons for continuous low-dose-rate irradiation of Chinese hamster cells.
Nath R; Bongiorni P; Chen Z; Gragnano J; Rockwell S
Radiat Res; 2005 May; 163(5):501-9. PubMed ID: 15850411
[TBL] [Abstract][Full Text] [Related]
30. Ocular brachytherapy dosimetry for 103Pd and 125I in the presence of gold nanoparticles: a Monte Carlo study.
Asadi S; Vaez-Zadeh M; Vahidian M; Marghchouei M; Masoudi SF
J Appl Clin Med Phys; 2016 May; 17(3):90-99. PubMed ID: 27167265
[TBL] [Abstract][Full Text] [Related]
31. Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants.
Yue N; Chen Z; Peschel R; Dicker AP; Waterman FM; Nath R
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1063-72. PubMed ID: 10571216
[TBL] [Abstract][Full Text] [Related]
32. Clinical relative biological effectiveness of low-energy x-rays emitted by miniature x-ray devices.
Brenner DJ; Leu CS; Beatty JF; Shefer RE
Phys Med Biol; 1999 Feb; 44(2):323-33. PubMed ID: 10070784
[TBL] [Abstract][Full Text] [Related]
33. Ytterbium-169: a promising new radionuclide for intravascular brachytherapy.
Patel NS; Fan P; Chiu-Tsao ST; Ravi K; Sherman W; Quon H; Pisch J; Tsao HS; Harrison LB
Cardiovasc Radiat Med; 2001; 2(3):173-80. PubMed ID: 11786324
[TBL] [Abstract][Full Text] [Related]
34. Monte Carlo calculation of dosimetry parameters for the IR08-103Pd brachytherapy source.
Saidi P; Sadeghi M; Shirazi A; Tenreiro C
Med Phys; 2010 Jun; 37(6):2509-15. PubMed ID: 20632562
[TBL] [Abstract][Full Text] [Related]
35. Dose rate constant and energy spectrum of interstitial brachytherapy sources.
Chen Z; Nath R
Med Phys; 2001 Jan; 28(1):86-96. PubMed ID: 11213926
[TBL] [Abstract][Full Text] [Related]
36. Determination of the intrinsic energy dependence of LiF:Mg,Ti thermoluminescent dosimeters for 125I and 103Pd brachytherapy sources relative to 60Co.
Reed JL; Rasmussen BE; Davis SD; Micka JA; Culberson WS; DeWerd LA
Med Phys; 2014 Dec; 41(12):122103. PubMed ID: 25471976
[TBL] [Abstract][Full Text] [Related]
37. A theoretical investigation into the role of tumour radiosensitivity, clonogen repopulation, tumour shrinkage and radionuclide RBE in permanent brachytherapy implants of 125I and 103Pd.
Antipas V; Dale RG; Coles IP
Phys Med Biol; 2001 Oct; 46(10):2557-69. PubMed ID: 11686275
[TBL] [Abstract][Full Text] [Related]
38. Monte Carlo simulations of ³He ion physical characteristics in a water phantom and evaluation of radiobiological effectiveness.
Taleei R; Guan F; Peeler C; Bronk L; Patel D; Mirkovic D; Grosshans DR; Mohan R; Titt U
Med Phys; 2016 Feb; 43(2):761-76. PubMed ID: 26843239
[TBL] [Abstract][Full Text] [Related]
39. Uncertainty in tissue equivalent proportional counter assessments of microdosimetry and RBE estimates in carbon radiotherapy.
Hartzell S; Guan F; Taylor P; Peterson C; Taddei P; Kry S
Phys Med Biol; 2021 Jul; 66(15):. PubMed ID: 34252894
[TBL] [Abstract][Full Text] [Related]
40. Comparison of calculated and measured heterogeneity correction factors for 125I, 137Cs, and 192Ir brachytherapy sources near localized heterogeneities.
Williamson JF; Perera H; Li Z; Lutz WR
Med Phys; 1993; 20(1):209-22. PubMed ID: 8455503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
